Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
Clinical trial NCT05680298 · COMPLETED
Trial details
- NCT number
- NCT05680298
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2023-12-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.